Literature DB >> 5474673

[The break-down of pentobarbital in hepatic diseases].

H F von Oldershausen, H Held, H Remmer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5474673     DOI： 10.1007/BF01488573

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


× No keyword cloud information.
  15 in total

1.  DIPHENYLHYDANTOIN AND PHENOBARBITAL TOXICITY. THE ROLE OF LIVER DISEASE.

Authors:  H KUTT; W WINTERS; R SCHERMAN; F MCDOWELL
Journal:  Arch Neurol       Date:  1964-12

2.  STUDIES OF PROLONGED-ACTION MEDICATION. III. PENTOBARBITAL SODIUM IN PROLONGED-ACTION FORM COMPARED WITH CONVENTIONAL CAPSULES: SERUM LEVELS OF DRUG AND CLINICAL EFFECTS FOLLOWING ACUTE DOSES.

Authors:  L E HOLLISTER; S L KANTER; D J CLYDE
Journal:  Clin Pharmacol Ther       Date:  1963 Sep-Oct       Impact factor: 6.875

3.  [Acceleration of oxidation of drugs during and after treatment with luminal].

Authors:  H REMMER; M SIEGERT; H W LIEBENSCHUETZ
Journal:  Klin Wochenschr       Date:  1961-05-01

4.  [Comparative examination of the oxidative functions of the mitochondria & microsomes in experimental liver injuries].

Authors:  D NEUBERT; D MAIBAUER
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1959

5.  [Barbiturate as a sleeping medicine in liver disease].

Authors:  W HAUBOLD
Journal:  Med Klin       Date:  1957-04-05

6.  Enzymatic oxidation of pentobarbital and thiopental.

Authors:  J R COOPER; B B BRODIE
Journal:  J Pharmacol Exp Ther       Date:  1957-05       Impact factor: 4.030

7.  [Pharmacokinetics of meprobamate in chronic liver diseases and drug addiction].

Authors:  H Held; H F von Oldershausen
Journal:  Klin Wochenschr       Date:  1969-01-15

8.  The alcoholic metabolites of pentobarbital and amobarbital in man.

Authors:  E W Maynert
Journal:  J Pharmacol Exp Ther       Date:  1965-10       Impact factor: 4.030

9.  [Induction of drug-decomposing enzymes into the endoplasmic reticulum of liver cells by pharmacologic agents].

Authors:  H Remmer
Journal:  Dtsch Med Wochenschr       Date:  1967-11-03       Impact factor: 0.628

10.  [The significance of cumulation and elimination for the determination of Phenytoin (diphenylhydantoin)].

Authors:  H Remmer; J Hirschmann; I Greiner
Journal:  Dtsch Med Wochenschr       Date:  1969-06-13       Impact factor: 0.628
View more
  7 in total

Review 1.  Clinical pharmacokinetics of hypnotics.

Authors:  D D Breimer
Journal:  Clin Pharmacokinet       Date:  1977 Mar-Apr       Impact factor: 6.447

2.  [Changes in the velocity of drug catabolism and their importance in drug therapy].

Authors:  G F Kahl
Journal:  Klin Wochenschr       Date:  1971-04-01

3.  Determination of drug metabolizing enzymes in needle biopsies of human liver.

Authors:  B Schoene; R A Fleischmann; H Remmer; H F von Oldershausen
Journal:  Eur J Clin Pharmacol       Date:  1972-03       Impact factor: 2.953

Review 4.  Drug prescribing in hepatobiliary disease.

Authors:  R K Roberts; P V Desmond; S Schenker
Journal:  Drugs       Date:  1979-03       Impact factor: 9.546

Review 5.  Clinical pharmacokinetic considerations in the treatment of increased intracranial pressure.

Authors:  G Heinemeyer
Journal:  Clin Pharmacokinet       Date:  1987-07       Impact factor: 6.447

6.  Impaired oxidation of debrisoquine in patients with perhexiline neuropathy.

Authors:  R R Shah; N S Oates; J R Idle; R L Smith; J D Lockhart
Journal:  Br Med J (Clin Res Ed)       Date:  1982-01-30

Review 7.  Sedation in Critically Ill Children with Respiratory Failure.

Authors:  Nienke J Vet; Niina Kleiber; Erwin Ista; Matthijs de Hoog; Saskia N de Wildt
Journal:  Front Pediatr       Date:  2016-08-24       Impact factor: 3.418
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.